VOLITIONRX LTD — Director's Dealing 2016

May 24, 2016

SEC Form 4/A — Form 4/A

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-04-20

Reporting Person: Reynolds Cameron John (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-20	Common Stock	X	1172	$2.6	Acquired	1105016	Direct

Footnotes

F1: The amount of securities beneficially owned was incorrectly reported in the original Form 4 due to the inadvertent failure to include the 1,172 shares which were originally reported as acquired on 04/20/2016.